| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |